As of mid-January 2026, major U.S. stock indexes have been trending lower following a series of mixed bank earnings reports and economic data releases, while gold and silver have reached record highs. In this context, investors often look to less conventional areas of the market for potential opportunities. Penny stocks, though considered a somewhat outdated term, still represent an intriguing investment area due to their potential for growth at lower price points. These smaller or newer companies can offer significant upside when backed by strong financials and sound fundamentals.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Rewards & Risks
Dingdong (Cayman) (DDL)	$2.72	$587.2M	✅ 3 ⚠️ 1 View Analysis >
Waterdrop (WDH)	$1.79	$650.99M	✅ 4 ⚠️ 0 View Analysis >
WM Technology (MAPS)	$0.8388	$145.16M	✅ 4 ⚠️ 1 View Analysis >
LexinFintech Holdings (LX)	$3.13	$535.08M	✅ 4 ⚠️ 2 View Analysis >
Tuya (TUYA)	$2.21	$1.34B	✅ 4 ⚠️ 1 View Analysis >
Golden Growers Cooperative (GGRO.U)	$5.00	$77.45M	✅ 1 ⚠️ 5 View Analysis >
Cricut (CRCT)	$4.49	$963.44M	✅ 2 ⚠️ 2 View Analysis >
VAALCO Energy (EGY)	$4.41	$434.76M	✅ 2 ⚠️ 3 View Analysis >
BAB (BABB)	$0.914975	$6.88M	✅ 2 ⚠️ 3 View Analysis >
Lifetime Brands (LCUT)	$4.05	$91.76M	✅ 3 ⚠️ 2 View Analysis >

Here's a peek at a few of the choices from the screener.

Freightos (CRGO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Freightos Limited operates a vendor-neutral booking and payment platform for international freight, with a market cap of $108.21 million.

Operations: Freightos Limited has not reported any specific revenue segments.

Market Cap: $108.21M

Freightos Limited, with a market cap of US$108.21 million, operates a digital platform for freight booking and payment. Despite its unprofitability and negative return on equity of -52.73%, the company has reduced losses over the past five years by 4.3% annually and reported Q3 2025 sales of US$7.67 million, up from US$6.19 million a year ago. The firm is debt-free with short-term assets exceeding liabilities, providing financial stability amidst volatility in its share price. Recent executive changes include CEO Zvi Schreiber stepping down to pursue other interests while remaining on the board as Pablo Pinillos assumes interim CEO duties.

Century Therapeutics (IPSC)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Century Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic cell therapies for treating solid tumors, hematological malignancies, and autoimmune diseases, with a market cap of $176.37 million.

Operations: The company generates revenue from its biotechnology startups segment, amounting to $113.34 million.

Market Cap: $176.37M

Century Therapeutics, Inc., with a market cap of US$176.37 million, remains pre-revenue despite its focus on developing cell therapies for complex diseases. The company recently secured significant funding through a private placement, raising approximately US$135 million to support its operations and development pipeline. Although unprofitable with a negative return on equity of -15.02%, Century has reduced losses over the past five years by 2.1% annually and maintains sufficient cash runway for more than a year due to strong short-term assets exceeding liabilities. Recent board changes include the addition of experienced directors Drs. Martin Murphy and Han Lee, enhancing governance as it navigates volatile share price conditions.

Planet Image International (YIBO)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Planet Image International Limited, with a market cap of $64.57 million, manufactures and sells compatible toner cartridges under both white-label and self-owned brands across North America, Europe, and internationally.

Operations: The company generates revenue of $147.07 million from its Printers & Related Products segment.

Market Cap: $64.57M

Planet Image International Limited, with a market cap of US$64.57 million, operates in the competitive toner cartridge market, generating US$147.07 million in revenue from its Printers & Related Products segment. Despite its unprofitability and negative return on equity of -8.97%, the company benefits from short-term assets (US$114.4 million) exceeding both short-term (US$77.4 million) and long-term liabilities (US$4.8 million). Debt management has improved significantly over five years, reducing the debt-to-equity ratio from 311.2% to 72.4%. The board is experienced with an average tenure of 4.6 years, though share price volatility remains high at 14%.

Next Steps

• Dive into all 335 of the US Penny Stocks we have identified here.
• Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 108 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.